PL1603872T3 - Krystaliczna sól chlorowodorku maleinianu S-[2-[(1-iminoetylo)amino]etylo]-2-metylo-L-cysteiny - Google Patents

Krystaliczna sól chlorowodorku maleinianu S-[2-[(1-iminoetylo)amino]etylo]-2-metylo-L-cysteiny

Info

Publication number: PL1603872T3
Authority: PL; Poland
Prior art keywords: iminoethyl; ethyl; amino; methyl; crystalline salt
Prior art date: 2003-03-11

Application number

PL04717188T

Other languages

English (en)

Inventor

Ahmad Sheikh

Lyle R Brostrom

Ann M Czyzewski

Vahid Zia

Original Assignee

Pharmacia Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-11

Filing date

2004-03-04

Publication date

2011-09-30

2004-03-04 Application filed by Pharmacia Corp filed Critical Pharmacia Corp

2011-09-30 Publication of PL1603872T3 publication Critical patent/PL1603872T3/pl

Links

QCVDKYGQDGDZJA-KZDSSNOQSA-N (2r)-2-amino-3-[2-(1-aminoethylideneamino)ethylsulfanyl]-2-methylpropanoic acid;(z)-but-2-enedioic acid Chemical compound OC(=O)\C=C/C(O)=O.CC(N)=NCCSC[C@](C)(N)C(O)=O QCVDKYGQDGDZJA-KZDSSNOQSA-N 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/26—Separation; Purification; Stabilisation; Use of additives
- C07C319/28—Separation; Purification
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Obesity (AREA)
Pregnancy & Childbirth (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)

PL04717188T 2003-03-11 2004-03-04 Krystaliczna sól chlorowodorku maleinianu S-[2-[(1-iminoetylo)amino]etylo]-2-metylo-L-cysteiny PL1603872T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US45349603P	2003-03-11	2003-03-11
EP04717188A EP1603872B1 (en)	2003-03-11	2004-03-04	S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
PCT/IB2004/000678 WO2004080956A1 (en)	2003-03-11	2004-03-04	S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt

Publications (1)

Publication Number	Publication Date
PL1603872T3 true PL1603872T3 (pl)	2011-09-30

Family

ID=32990778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04717188T PL1603872T3 (pl)	2003-03-11	2004-03-04	Krystaliczna sól chlorowodorku maleinianu S-[2-[(1-iminoetylo)amino]etylo]-2-metylo-L-cysteiny

Country Status (32)

Country	Link
US (2)	US20050038120A1 (pl)
EP (1)	EP1603872B1 (pl)
JP (1)	JP4794433B2 (pl)
KR (2)	KR20090048521A (pl)
CN (1)	CN100460387C (pl)
AR (1)	AR043521A1 (pl)
AT (1)	ATE509909T1 (pl)
AU (1)	AU2004220266B2 (pl)
BR (1)	BRPI0408226A (pl)
CA (1)	CA2518745C (pl)
CL (1)	CL2004000472A1 (pl)
CO (1)	CO5611122A2 (pl)
CY (1)	CY1112461T1 (pl)
DK (1)	DK1603872T3 (pl)
ES (1)	ES2363001T3 (pl)
GT (1)	GT200400040A (pl)
IL (1)	IL170554A (pl)
MX (1)	MXPA05008674A (pl)
NL (1)	NL1025691C2 (pl)
NO (1)	NO20054645L (pl)
NZ (1)	NZ574218A (pl)
PA (1)	PA8597701A1 (pl)
PE (1)	PE20050309A1 (pl)
PL (1)	PL1603872T3 (pl)
PT (1)	PT1603872E (pl)
RU (1)	RU2357953C2 (pl)
SG (1)	SG155782A1 (pl)
SI (1)	SI1603872T1 (pl)
TW (1)	TWI352076B (pl)
UY (1)	UY28229A1 (pl)
WO (1)	WO2004080956A1 (pl)
ZA (1)	ZA200506459B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6094101A (en) *	1999-03-17	2000-07-25	Tropian, Inc.	Direct digital frequency synthesis enabling spur elimination
PT1793187E (pt) *	2004-09-21	2012-03-05	Joan Vives Iglesias	Processo e máquina destinados à sinterização e/ou secagem de materiais em pó utilizando uma radiação infravermelha

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9103572D0 (sv) *	1991-11-29	1991-11-29	Astra Ab	Organic salts of n,n'-diacetyl cystine
DE69529101T2 (de) *	1994-06-15	2003-11-13	Wellcome Found	Zwischenprodukte verwendbar in der Herstellung von Enzym-Inhibitoren
MY117948A (en) *	1997-01-13	2004-08-30	Glaxo Group Ltd	Nitride oxide synthase inhibitors.
GEP20094625B (en) *	2000-03-24	2009-03-10	Pharmacia Corp	Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
AR031609A1 (es) *	2000-09-15	2003-09-24	Pharmacia Corp	Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa
AR031608A1 (es) *	2000-09-15	2003-09-24	Pharmacia Corp	Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa

2004
- 2004-03-04 AT AT04717188T patent/ATE509909T1/de active
- 2004-03-04 EP EP04717188A patent/EP1603872B1/en not_active Expired - Lifetime
- 2004-03-04 AU AU2004220266A patent/AU2004220266B2/en not_active Ceased
- 2004-03-04 CA CA2518745A patent/CA2518745C/en not_active Expired - Fee Related
- 2004-03-04 SG SG200802031-5A patent/SG155782A1/en unknown
- 2004-03-04 NZ NZ574218A patent/NZ574218A/en not_active IP Right Cessation
- 2004-03-04 BR BRPI0408226-5A patent/BRPI0408226A/pt not_active IP Right Cessation
- 2004-03-04 SI SI200431696T patent/SI1603872T1/sl unknown
- 2004-03-04 MX MXPA05008674A patent/MXPA05008674A/es active IP Right Grant
- 2004-03-04 PL PL04717188T patent/PL1603872T3/pl unknown
- 2004-03-04 WO PCT/IB2004/000678 patent/WO2004080956A1/en not_active Ceased
- 2004-03-04 KR KR1020097008258A patent/KR20090048521A/ko not_active Ceased
- 2004-03-04 ES ES04717188T patent/ES2363001T3/es not_active Expired - Lifetime
- 2004-03-04 JP JP2006506318A patent/JP4794433B2/ja not_active Expired - Fee Related
- 2004-03-04 PT PT04717188T patent/PT1603872E/pt unknown
- 2004-03-04 CN CNB200480012896XA patent/CN100460387C/zh not_active Expired - Fee Related
- 2004-03-04 DK DK04717188.9T patent/DK1603872T3/da active
- 2004-03-04 RU RU2005125833/04A patent/RU2357953C2/ru not_active IP Right Cessation
- 2004-03-04 KR KR1020057016858A patent/KR100927911B1/ko not_active Expired - Fee Related
- 2004-03-09 AR ARP040100751A patent/AR043521A1/es not_active Application Discontinuation
- 2004-03-09 CL CL200400472A patent/CL2004000472A1/es unknown
- 2004-03-09 PE PE2004000257A patent/PE20050309A1/es not_active Application Discontinuation
- 2004-03-10 GT GT200400040A patent/GT200400040A/es unknown
- 2004-03-10 TW TW093106315A patent/TWI352076B/zh not_active IP Right Cessation
- 2004-03-10 US US10/797,462 patent/US20050038120A1/en not_active Abandoned
- 2004-03-10 PA PA20048597701A patent/PA8597701A1/es unknown
- 2004-03-11 UY UY28229A patent/UY28229A1/es not_active Application Discontinuation
- 2004-03-11 NL NL1025691A patent/NL1025691C2/nl not_active IP Right Cessation
2005
- 2005-08-11 ZA ZA200506459A patent/ZA200506459B/en unknown
- 2005-08-29 IL IL170554A patent/IL170554A/en not_active IP Right Cessation
- 2005-09-09 CO CO05091013A patent/CO5611122A2/es not_active Application Discontinuation
- 2005-10-10 NO NO20054645A patent/NO20054645L/no not_active Application Discontinuation
2008
- 2008-12-05 US US12/315,744 patent/US7767850B2/en not_active Expired - Fee Related
2011
- 2011-06-06 CY CY20111100540T patent/CY1112461T1/el unknown

Also Published As

Publication number	Publication date
AR043521A1 (es)	2005-08-03
KR20050107617A (ko)	2005-11-14
MXPA05008674A (es)	2005-10-18
NO20054645L (no)	2005-11-25
CA2518745A1 (en)	2004-09-23
TW200508185A (en)	2005-03-01
US7767850B2 (en)	2010-08-03
AU2004220266A1 (en)	2004-09-23
RU2357953C2 (ru)	2009-06-10
US20050038120A1 (en)	2005-02-17
NO20054645D0 (no)	2005-10-10
KR100927911B1 (ko)	2009-11-19
SG155782A1 (en)	2009-10-29
KR20090048521A (ko)	2009-05-13
NZ574218A (en)	2009-11-27
JP2006519838A (ja)	2006-08-31
DK1603872T3 (da)	2011-07-18
GT200400040A (es)	2005-01-14
CY1112461T1 (el)	2015-12-09
CO5611122A2 (es)	2006-02-28
ZA200506459B (en)	2006-11-29
CL2004000472A1 (es)	2005-05-13
TWI352076B (en)	2011-11-11
UY28229A1 (es)	2004-11-08
CA2518745C (en)	2010-10-19
BRPI0408226A (pt)	2006-03-01
JP4794433B2 (ja)	2011-10-19
US20090215891A1 (en)	2009-08-27
CN1787993A (zh)	2006-06-14
PE20050309A1 (es)	2005-05-04
EP1603872B1 (en)	2011-05-18
AU2004220266B2 (en)	2010-08-19
PA8597701A1 (es)	2005-02-04
WO2004080956A1 (en)	2004-09-23
HK1088301A1 (en)	2006-11-03
ATE509909T1 (de)	2011-06-15
IL170554A (en)	2011-10-31
ES2363001T3 (es)	2011-07-18
NL1025691A1 (nl)	2004-09-14
CN100460387C (zh)	2009-02-11
RU2005125833A (ru)	2006-05-10
SI1603872T1 (sl)	2011-07-29
PT1603872E (pt)	2011-06-07
EP1603872A1 (en)	2005-12-14
NL1025691C2 (nl)	2006-06-30

Publication	Publication Date	Title
PL360967A1 (pl)	2004-01-12	Kompozycja farmaceutyczna zawierająca chlorowodorek donepezylu
GEP20094625B (en)	2009-03-10	Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
PL372626A1 (pl)	2005-07-25	Pochodne peptydów zawierające grupę tiazepinową jako środki do leczenia stanów hiperlipidemicznych
IL164185A0 (en)	2005-12-18	Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives
IL164155A (en)	2012-03-29	Method for the preparation of crystalline quetiapine hemifumarate form i
AU2003227360A1 (en)	2003-11-10	Novel amide derivatives or salts thereof
ZA200501418B (en)	2006-10-25	Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
PL379385A1 (pl)	2006-09-04	Nowe związki 2-pirydynyloetylobenzamidowe
AU2003214112A1 (en)	2003-09-22	Salts of nateglinide
HRP20041092A2 (en)	2005-06-30	New pharmaceutical compositions containing filbanserin polymorph a
HUP0401694A3 (en)	2008-03-28	Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use
AU2003269747A1 (en)	2003-12-02	A stable aqueous composition of a peptide
IL170037A (en)	2010-12-30	Synthesis of quetiapine and quetiapine hemifumarate salt
AU2003295579A1 (en)	2004-06-15	Anti-microbial agents derived from methionine sulfoximine analogues
PT1499587E (pt)	2014-11-21	Processo para síntese de sais de dissulfureto farmaceuticamente activos
PL1603872T3 (pl)	2011-09-30	Krystaliczna sól chlorowodorku maleinianu S-[2-[(1-iminoetylo)amino]etylo]-2-metylo-L-cysteiny
SI2495251T1 (sl)	2014-07-31	Hidrokloridne soli derivata glikopeptid fosfonata
GB0211626D0 (en)	2002-07-03	Succinnylated fish gelatin for use as a blood plasma expander
AU2002352825A1 (en)	2004-06-15	Human methionine aminopeptidase type 3
TW200503680A (en)	2005-02-01	S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate form ii crystalline salt
TW200504000A (en)	2005-02-01	Methods for selectively removing counterions from compounds and compounds derived from such methods
MXPA05009779A (es)	2005-10-26	Sal cristalina de salicilato de s-[2-[(1-iminoetil)amino]etil]-2-metil-l-cisteina monohidrato.
ITBO20040045A1 (it)	2004-05-03	Procedimento per l'applicazione di un inserto in una cinghia dentata
MXPA05009302A (es)	2005-10-05	Sal cristalina de maleato de s-[2-[(1-iminoetil)amino]etil]-2-metil-l-cisteina.
GB0204683D0 (en)	2002-04-17	Pharmaceutical salts